NCT03805607View on ClinicalTrials.gov

IV Ketorolac on Platelet Function Post-Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

February 3, 2022

Study Completion Date

March 30, 2024

Conditions
Analgesia, ObstetricalCoagulation Defect; PostpartumNonsteroidals (NSAIDs)ToxicityPostpartum HemorrhagePostoperative PainKetorolac Adverse ReactionBlood Loss, Postoperative
Interventions
DRUG

Ketorolac Tromethamine 30 MG/ML

Ketorolac 30 mg

DRUG

Placebos

Normal Saline

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Society for Obstetric Anesthesia and Perinatology

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT03805607 - IV Ketorolac on Platelet Function Post-Cesarean Delivery | Biotech Hunter | Biotech Hunter